FRIDAY, June 19, 2020 -- If you have diabetes and live in rural America, the closest specialist may be hours away. But new research shows that effective help may be as close as your phone.
The study found that a six-month telehealth program led to a significant drop in blood sugar levels. Participants had an average A1C level of 9.25% at the study's start and an average of 7.89% at the end. That benefit was maintained a year after the study ended.
WEDNESDAY, June 17, 2020 -- Technology often makes life easier to manage, and new research confirms that's definitely the case for people with type 1 diabetes.
Continuous glucose monitors -- devices that approximate blood sugar levels every few minutes -- can help teens and young adults better manage their diabetes. They can also help older adults prevent dangerously low blood sugar levels (hypoglycemia), according to two new studies.
TUESDAY, June 16, 2020 -- With U.S. coronavirus cases now past 2 million, a new report finds that COVID-19 is much more lethal for Americans with underlying health issues -- illnesses such as heart disease, diabetes or lung ailments.
In fact, "deaths were 12 times higher among patients with reported underlying conditions," compared to healthy individuals, according to an analysis of more than 1.3 million cases of COVID-19 reported to the U.S. Centers for Disease Control and Prevention by May 30.
FRIDAY, May 1, 2020 -- An Australian study has good news for people with type 2 diabetes -- fewer people with diabetes are having heart attacks and strokes compared to 20 years ago.
Heart attacks, strokes and other cardiovascular complications have declined in the general population, too. But the decreases among people with diabetes have outpaced those for the general population, the researchers said.
FRIDAY, April 24, 2020 -- Contact lenses may someday do more than correct poor vision, with new, preliminary research in animals suggesting they could also monitor your diabetes and deliver medications.
The new lenses were designed to check blood sugar levels and to deliver drugs to the eye, possibly for the eye disease related to diabetes called diabetic retinopathy. After trying them out on rabbits, scientists found the new lenses worked on both counts.